Protective effects of naloxone in two-hit seizure model

Epilepsia

Volumn 51, Issue 3, 2010, Pages 344-353

  Yang, Lu ^a   Li, Fuhai ^a   Ge, Wei ^a   Mi, Changrui ^a   Wang, Rong ^a   Sun, Ruopeng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Astrocytes; In situ nick end labeling; Microglia; Naloxone; Rats; Status epilepticus

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1BETA; KAINIC ACID; NALOXONE; PROTEIN S100B;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIA; MALE; MICROGLIA; NERVE INJURY; NICK END LABELING; NONHUMAN; OSMOTIC MINIPUMP; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SEIZURE; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; ASTROCYTES; BEHAVIOR, ANIMAL; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; IN SITU NICK-END LABELING; INTERLEUKIN-1BETA; KAINIC ACID; MAZE LEARNING; MICROGLIA; NALOXONE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; STATUS EPILEPTICUS;

EID: 77749233734     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02250.x     Document Type: Article

References (35)

1. Belluardo N, Mudo G, Jiang XH, Condorelli DF. (1996) Induction of astroglial gene expression by experimental seizures in the rat: spatiotemporal patterns of the early stages. Glia 16:174-186.
2. Biber K, Neumann H, Inoue K, Boddeke HW. (2007) Neuronal 'On' and 'Off' signals control microglia. Trends Neurosci 30:596-602.
3. Binder DK, Steinhäuser C. (2006) Functional changes in astroglial cells in epilepsy. Glia 54:358-368.
4. Chen CS, Gates GR, Reynoldson JA. (1976) Effects of morphine and naloxone on priming-induced audiogenic seizures in BALB/c mice. Br J Pharmacol 58:517-520.
5. Craft JM, Watterson DM, Marks A, Van Eldik LJ. (2005) Enhanced susceptibility of S-100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human β-amyloid. Glia 51:209-216.
6. Donato R. (2003) Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 60:540-551.
7. Faden I. A., Salzman S. (1992) Pharmacological strategies in CNS trauma. Trends Pharmacol Sci 13:29-35.
8. Hardy C, Panksepp J, Rossi J 3rd, Zolovick AJ. (1980) Naloxone facilitates amygdaloid kindling in rats. Brain Res 194:293-297.
9. Iijima I, Minamikawa J, Jacobson AE, Brossi A, Rice KC. (1978) Studies in the (+)-morphinan series.5.Synthesis and biological properties of (+)-naloxone. J Med Chem 21:398-400.
10. Khurgel M, Switzer RC 3rd, Teskey GC, Spiller AE, Racine RJ, Ivy GO. (1995) Activation of astrocytes during epileptogenesis in the absence of neuronal degeneration. Neurobiol Dis 2:23-35.
11. Koh S, Storey TW, Santos TC, Mian AY, Cole AJ. (1999) Early-life seizures in rats increase susceptibility to seizure-induced brain injury in adulthood. Neurology 53:915-921.
12. Liao SL, Chen WY, Raung SL, Chen CJ. (2003) Neuroprotection of naloxone against ischemic injury in rats: role of mu receptor antagonism. Neurosci Lett 345:169-172.
13. Liu B, Hong JS. (2003) Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304:1-7.
14. Liu B, Du L, Hong JS. (2000a) Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther 293:607-617.
15. Liu B, Du L, Kong LY, Hudson PM, Wilson BC, Chang RC, Abel HH, Hong JS. (2000b) Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures. Neuroscience 97:749-756.
16. Liu B, Jiang JW, Wilson BC, Du L, Yang SN, Wang JY, Wu GC, Cao XD, Hong JS. (2000c) Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. J Pharmacol Exp Ther 295:125-132.
17. Liu Y, Qin L, Wilson BC, An L, Hong JS, Liu B. (2002) Inhibition by naloxone stereoisomers of beta-amyloid peptide (1-42)-induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons. J Pharmacol Exp Ther 302:1212-1219.
18. Maytal J, Shinnar S, Moshe SL, Alvarez LA. (1989) Low morbidity and mortality of status epilepticus in children. Pediatrics 83:323-331.
19. Meldrum BS, Menini C, Stutzmann JM, Naquet R. (1979) Effects of opiate-like peptides, morphine, and naloxone in the photosensitive baboon, Papio papio. Brain Res 170:333-348.
20. Ni YQ, Xu GZ, Hu WZ, Shi L, Qin YW, Da CD. (2008) Neuroprotective effects of naloxone against light-induced photoreceptor degeneration through inhibiting retinal microglial activation. Invest Ophthalmol Vis Sci 49:2589-2598.
21. Oprica M, Eriksson C, Schultzberg M. (2003) Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system. J Cell Mol Med 7:17-140.
22. Priller J, Haas CA, Reddington M, Kreutzberg GW. (1995) Calcitonin gene-related peptide and ATP induce immediate early gene expression in cultured rat microglial cells. Glia 15:447-457.
23. Prow NA, Irani DN. (2007) The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis. Exp Neurol 205:461-470.
24. Puig MM, Miralles F, Laorden L. (1986) Naloxone prevents hyperthermia induced convulsions in the immature rat. Methods Find Exp Clin Pharmacol 8:649-653.
25. Ravizza T, Rizzi M, Perego C, Richichi C, Velísková J, Moshé SL, De Simoni MG, Vezzani A. (2005) Inflammatory response and glia activation in developing rat hippocampus after status epilepticus. Epilepsia 46:113-117.
26. Rizzi M, Perego C, Aliprandi M, Richichi C, Ravizza T, Colella D, Velískǒvá J, Moshé SL, De Simoni MG, Vezzani A. (2003) Glia activation and cytokine increase in rat hippocampus by kainic acid-induced status epilepticus during postnatal development. Neurobiol Dis 14:494-503.
27. Schmid R, Tandon P, Stafstrom CE, Holmes GL. (1999) Effects of neonatal seizures on subsequent seizure-induced brain injury. Neurology 53:1754-1761.
28. Snyder EW, Shearer DE, Beck EC, Dustmann RE. (1980) Naloxone-induced electrographic seizures in the primate. Psychopharmacology (Berl) 67:211-214.
29. Somera-Molina KC, Robin B, Somera CA, Anderson C, Stine C, Koh S, Behanna HV, Van Eldik LJ, Watterson DM, Wainwright MS. (2007) Glial activation links early-life seizures and long-term neurological dysfunction: evidence using a small molecule inhibitor of proinflammatory cytokine upregulation. Epilepsia 48:1785-1800.
30. Streit WJ, Walter SA, Pennell NA. (1999) Reactive microgliosis. Prog Neurobiol 57:563-581.
31. Taniwaki Y, Kato M, Araki T, Kobayashi T. (1996) Microglial activation by epileptic activities through the propagation pathway of kainic acid-induced hippocampal seizures in the rat. Neurosci Lett 217:29-32.
32. Turski L, Ikonomidou C, Cavalheiro EA, Kleinrok Z, Czuczwar SJm Turski WA. (1985) Effects of morphine and naloxone on pilocarpine-induced convulsions in rats. Neuropeptides 5:315-318.
33. Vezzani A, Moneta D, Richichi C, Aliprandi M, Burrows SJ, Ravizza T, Perego C, De Simoni MG. (2002) Functional role of inflammatory cytokines and anti-inflammatory molecules in seizures and epileptogenesis. Epilepsia 5:30-35.
34. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M. (2003) Interleukin-1 beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23:8692-8700.
35. Wainwright MS, Craft JM, Griffin WS, Marks A, Pineda J, Padgett KR, Van Eldik LJ. (2004) Increased susceptibility of S100B transgenic mice to perinatal hypoxia-ischemia. Ann Neurol 56:61-67.